Beam Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-72.0M | $-84.5M | $12.5M | $7.0M |
| FY2020 | $-95.7M | $-112.1M | $16.4M | $15.4M |
| FY2021 | $-66.3M | $-113.1M | $46.8M | $43.6M |
| FY2022 | $22.5M | $-26.4M | $49.0M | $84.3M |
| FY2023 | $-149.2M | $-182.9M | $33.7M | $98.6M |
| FY2024 | $-347.2M | $-356.2M | $8.9M | $120.7M |
| FY2025 | $-345.1M | $-360.0M | $14.9M | $94.2M |